Anixa Biosciences, Inc. Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Anixa Biosciences, Inc. is a clinical-stage biotechnology company based in San Jose, California, focused on the treatment and prevention of cancer. Its therapeutic program for ovarian cancer is developed in collaboration with Moffitt Cancer Center and uses a chimeric endocrine receptor-T cell approach. The company is also developing cancer vaccines with Cleveland Clinic to address breast and ovarian cancers, plus additional vaccines aimed at other high-incidence cancers such as those of the lung, colon, and prostate. Anixa emphasizes partnerships with leading research institutions to advance technologies through development toward potential commercialization. In April 2026, the company announced that its leadership would participate in two investor conferences, signaling ongoing engagement with the investment community.